Profiling gut bacteria in patients with severe alcoholic hepatitis
Official title: Intestinal Microbiota Profiling in HAA Patients
Run by Centre Hospitalier Universitaire, Amiens · NCT06159244 · Data updated 2026-11-12
This study is testing if the types of gut bacteria in patients with severe alcoholic hepatitis can help predict how well they respond to corticosteroid treatment, with or without fecal microbiota transplantation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Centre Hospitalier Universitaire, Amiens Academic / other |
| Locations | 1 site (Amiens, Picardie) |
| Status | Recruiting |
| Started | November 15, 2023 |
| Main results expected | November 2028 |
| Study ends | November 2028 |
| Registry record updated | May 25, 2025 |
| Trial ID | NCT06159244 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 to 75 with a confirmed diagnosis of severe acute alcoholic hepatitis and a high Maddrey score.
✕Probably not a fit
Patients with other liver diseases, uncontrolled liver complications, or those outside the age range may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the intestinal microbiota profiles of patients suffering from severe acute alcoholic hepatitis. It aims to identify specific microbiota signatures that may correlate with treatment responses to corticosteroids, either alone or in combination with fecal microbiota transplantation (FMT). By analyzing these profiles, the study seeks to enhance understanding of how gut bacteria influence the effectiveness of corticosteroid therapy in this patient population. The ultimate goal is to provide clinicians with rapid and simple tools to predict treatment outcomes based on microbiota composition.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for patients with severe alcoholic hepatitis, potentially enhancing survival rates.
How similar studies have gone: While the specific approach of profiling intestinal microbiota in this context may be novel, there is growing interest in the role of gut bacteria in liver diseases, suggesting potential for success based on related research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged from 18 to 75 years, having : * Heavy drinker with Maddrey Score ≥ 32 : PT(second)-PT(control)x4.6+Bilirubine (mg/dl) * Histological confirmed Alcoholic hepatitis * Personal consent signed to the trial * No exclusion criteria Exclusion Criteria: * Age \< 18 years and/or \> 75 years, * Pregnancy or lactating females, * No personal consent * Other causes of liver disease: chronic hepatitis B (antigen HBs positive), hepatitis C (HCV RNA positive), acetaminophen hepatotoxicity, biliary obstruction, autoimmune hepatitis, primary biliary cholangitis, primary sclerosis cholangitis, alpha 1 antitrypsine deficiency, and Wilson disease. * Uncontrolled liver complications: * Upper gastrointestinal bleed by portal hypertension (4 days required for stable condition) * Active sepsis (4 days required for stable condition) * Patient currently treated by antibiotic * Concomitant Liver cancer (HCC) or extrahepatic malignancy * Type 1 hepatorenal syndrome (HRS) or renal failure defined as a serum creatinine \>221 μmol/L (\>2.5 mg/dL) or the requirement for renal replacement therapy * Grade 4 Hepatic Encephalopathy (HE) by West Haven criteria * Individuals dependent on inotropic (eg, epinephrine or norepinephrine) or ventilatory support (ie, endotracheal intubation or positive-pressure ventilation) * Disseminated intravascular coagulation * Intestinal paralysis * History of liver transplantation Other general diseases or severe conditions: * HIV disease * Intestinal paralysis * Intestinal inflammatory disease (Crohn or Ulcerative colitis) * Clostridium difficilae infection * Clinical suspicion of pneumonia * Uncontrolled sepsis * Acute Alcoholic pancreatitis * Noncontrolled alcohol withdrawal syndrome * Cardiac or respiratory bad conditions
Where it's running
-
CHU Amiens Picardie
Amiens, Picardie, France Recruiting
Study contacts
- Study coordinator: Eric Nguyen-Khac, Pr
- Email: nguyen-khac.eric@chu-amiens.fr
- Phone: 0322088851
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Optimized Flow for Obese Patients Undergoing Heart Surgery
In this study, researchers will test whether using ideal body weight to set cardiopulmonary bypass flow during heart surgery helps obese adults see fewer transfusions and related complications.
-
See if small fiber neuropathy is common in people with primary Sjögren’s syndrome
This study tests whether small fiber neuropathy is common in adults with primary Sjögren’s syndrome using a quick, non-invasive Sudoscan test.
-
Tramadol vs Morphine for Postoperative Pain After Laparoscopic Abdominal Surgery
This study tests whether tramadol can provide comparable pain relief to morphine after laparoscopic abdominal surgery when used as part of multimodal pain management.
-
Using infrared cameras to help detect juvenile arthritis in kids
This study tests whether infrared thermography can help identify joint inflammation in children with juvenile idiopathic arthritis compared with standard tests.
-
Hypothalamus structure and heart autonomic changes in drug-resistant epilepsy
This study tests whether structural changes in the hypothalamus relate to cardiac autonomic dysfunction in adults with drug-resistant epilepsy.
-
15-year outcomes after sleeve gastrectomy in France
This study looks at how people who had sleeve gastrectomy have fared over 15 years to see long-term weight changes and health effects.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.